The purpose of this study is to evaluate th safety and efficacy of one-daily topical application of CLS001 low, mid and high dose compared to vehicle gel in subjects with papulopustular rosacea.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Enrollment
240
Radiant Research Inc.
Birmingham, Alabama, United States
ATS Clinical Research
Santa Monica, California, United States
Change in inflammatory lesion count
Time frame: 0, 1, 3, 6, 9 and 12 weeks
Success on IGA defined as clear or almost clear
Time frame: Week 12
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
The Savin Center, PC
New Haven, Connecticut, United States
Skin Care Research, Inc
Boca Raton, Florida, United States
Dunedin Research Specialists
Dunedin, Florida, United States
North Florida Dermatology Associates
Jacksonville, Florida, United States
Dawes Fretzin Clinical Research Group
Indianapolis, Indiana, United States
Grekin Skin Institute
Warren, Michigan, United States
Rochester General Medical Group Center for Dermatology at Linden Oaks
Rochester, New York, United States
Derm Research Center of NY Inc.
Stoney Brook, New York, United States
...and 7 more locations